$38.49
1.022.72%
In chiusura: -
$38.35
-0.14-0.36%
After hour: Oct 3, 4:00 PM EDT
Il short interest su Kiniksa Pharmaceuticals International PLC (NASDAQ:KNSA) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 2.71M a 2.43M. Questo rappresenta il 6.07% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Kiniksa Pharmaceuticals Corp (XNAS:KNSA) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 472.92K azioni scambiate al giorno, ci vorrebbero 5.15 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|
KNSA | Kiniksa Pharmaceuticals Intern | 09/15/2025 | 09/24/2025 | 6.07% | 40,069,874 | 2,433,456 | 472,916 | 5.15 | |
KNSA | Kiniksa Pharmaceuticals Intern | 08/29/2025 | 09/10/2025 | 6.76% | 40,069,874 | 2,707,472 | 378,535 | 7.15 | |
KNSA | Kiniksa Pharmaceuticals Intern | 08/15/2025 | 08/26/2025 | 5.22% | 40,069,874 | 2,092,794 | 684,030 | 3.06 | |
KNSA | Kiniksa Pharmaceuticals Intern | 07/31/2025 | 08/11/2025 | 6.06% | 40,069,874 | 2,429,505 | 696,279 | 3.49 | |
KNSA | Kiniksa Pharmaceuticals Intern | 07/15/2025 | 07/24/2025 | 6.51% | 38,933,173 | 2,533,519 | 594,478 | 4.26 | |
KNSA | Kiniksa Pharmaceuticals Intern | 06/30/2025 | 07/10/2025 | 5.31% | 38,933,173 | 2,066,717 | 1,428,132 | 1.45 | |
KNSA | Kiniksa Pharmaceuticals Intern | 06/13/2025 | 06/25/2025 | 6.06% | 38,933,173 | 2,359,063 | 863,236 | 2.73 | |
KNSA | Kiniksa Pharmaceuticals Intern | 05/30/2025 | 06/10/2025 | 6.98% | 38,933,173 | 2,718,015 | 497,988 | 5.46 | |
KNSA | Kiniksa Pharmaceuticals Intern | 05/15/2025 | 05/27/2025 | 8.49% | 38,933,173 | 3,305,668 | 498,386 | 6.63 | |
KNSA | Kiniksa Pharmaceuticals Intern | 04/30/2025 | 05/09/2025 | 8.54% | 38,933,173 | 3,326,674 | 790,245 | 4.21 | |
KNSA | Kiniksa Pharmaceuticals Intern | 04/15/2025 | 04/25/2025 | 10.13% | 32,742,279 | 3,316,011 | 686,222 | 4.83 | |
KNSA | Kiniksa Pharmaceuticals Intern | 03/31/2025 | 04/09/2025 | 9.56% | 32,742,279 | 3,129,716 | 508,298 | 6.16 | |
KNSA | Kiniksa Pharmaceuticals Intern | 03/14/2025 | 03/25/2025 | 9.38% | 32,742,279 | 3,072,555 | 830,656 | 3.7 | |
KNSA | Kiniksa Pharmaceuticals Intern | 02/28/2025 | 03/11/2025 | 9.16% | 32,742,279 | 3,000,815 | 532,104 | 5.64 | |
KNSA | Kiniksa Pharmaceuticals Intern | 02/14/2025 | 02/26/2025 | 9.04% | 32,742,279 | 2,961,419 | 603,334 | 4.91 | |
KNSA | Kiniksa Pharmaceuticals Intern | 01/31/2025 | 02/11/2025 | 5.97% | 32,299,604 | 1,929,100 | 604,826 | 3.19 | |
KNSA | Kiniksa Pharmaceuticals Intern | 01/15/2025 | 01/27/2025 | 6.53% | 32,299,604 | 2,109,178 | 510,810 | 4.13 | |
KNSA | Kiniksa Pharmaceuticals Intern | 12/31/2024 | 01/10/2025 | 10.49% | 32,299,604 | 3,388,499 | 425,113 | 7.97 | |
KNSA | Kiniksa Pharmaceuticals Intern | 12/13/2024 | 12/24/2024 | 10.09% | 32,299,604 | 3,257,519 | 272,542 | 11.95 | |
KNSA | Kiniksa Pharmaceuticals Intern | 11/29/2024 | 12/10/2024 | 12.44% | 32,299,604 | 4,019,468 | 241,655 | 16.63 | |
KNSA | Kiniksa Pharmaceuticals Intern | 11/15/2024 | 11/26/2024 | 12.74% | 32,299,604 | 4,114,568 | 339,635 | 12.11 | |
KNSA | Kiniksa Pharmaceuticals Intern | 10/31/2024 | 11/11/2024 | 13.05% | 32,299,604 | 4,214,677 | 318,248 | 13.24 | |
KNSA | Kiniksa Pharmaceuticals Intern | 10/15/2024 | 10/24/2024 | 12.78% | 31,341,751 | 4,006,718 | 291,964 | 13.72 | |
KNSA | Kiniksa Pharmaceuticals Intern | 09/30/2024 | 10/09/2024 | 13.04% | 31,341,751 | 4,087,264 | 640,398 | 6.38 | |
KNSA | Kiniksa Pharmaceuticals Intern | 09/13/2024 | 09/24/2024 | 14.79% | 31,341,751 | 4,636,433 | 304,148 | 15.24 | |
KNSA | Kiniksa Pharmaceuticals Intern | 08/30/2024 | 09/11/2024 | 14.52% | 31,341,751 | 4,549,901 | 275,621 | 16.51 | |
KNSA | Kiniksa Pharmaceuticals Intern | 07/31/2024 | 08/09/2024 | 14.39% | 31,341,751 | 4,509,334 | 774,578 | 5.82 | |
KNSA | Kiniksa Pharmaceuticals Intern | 07/15/2024 | 07/24/2024 | 12.65% | 31,180,317 | 3,943,352 | 436,520 | 9.03 | |
KNSA | Kiniksa Pharmaceuticals Intern | 06/28/2024 | 07/10/2024 | 14.64% | 31,180,317 | 4,563,301 | 634,539 | 7.19 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 06/14/2024 | 06/26/2024 | 15.02% | 31,038,184 | 4,663,204 | 271,826 | 17.16 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 05/31/2024 | 06/11/2024 | 13.26% | 31,038,184 | 4,117,196 | 294,208 | 13.99 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 05/15/2024 | 05/24/2024 | 12.86% | 31,038,184 | 3,990,186 | 326,637 | 12.22 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 04/30/2024 | 05/09/2024 | 12.61% | 31,038,184 | 3,914,162 | 429,172 | 9.12 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 04/15/2024 | 04/24/2024 | 11.74% | 31,038,184 | 3,643,645 | 335,938 | 10.85 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 03/28/2024 | 04/09/2024 | 8.78% | 36,551,188 | 3,209,806 | 349,990 | 9.17 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 03/15/2024 | 03/26/2024 | 7.85% | 36,551,188 | 2,867,473 | 482,611 | 5.94 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 02/29/2024 | 03/11/2024 | 7.61% | 36,551,188 | 2,779,945 | 345,392 | 8.05 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 02/15/2024 | 02/27/2024 | 8.44% | 31,980,616 | 2,700,234 | 319,719 | 8.45 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 01/31/2024 | 02/09/2024 | 8.62% | 31,980,616 | 2,756,719 | 278,775 | 9.89 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 01/12/2024 | 01/24/2024 | 8.17% | 31,980,616 | 2,612,971 | 726,657 | 3.6 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 12/29/2023 | 01/10/2024 | 8.98% | 31,980,616 | 2,870,655 | 550,006 | 5.22 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 12/15/2023 | 12/27/2023 | 10.24% | 31,980,616 | 3,275,580 | 487,175 | 6.72 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 11/30/2023 | 12/11/2023 | 10.73% | 31,980,616 | 3,430,409 | 325,119 | 10.55 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 11/15/2023 | 11/27/2023 | 10.67% | 31,980,616 | 3,412,283 | 553,425 | 6.17 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 10/31/2023 | 11/09/2023 | 10.05% | 31,980,616 | 3,213,840 | 369,783 | 8.69 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 10/13/2023 | 10/24/2023 | 12.26% | 31,809,160 | 3,899,820 | 268,484 | 14.53 | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 09/29/2023 | 10/10/2023 | 12.16% | 31,809,160 | 3,866,548 | 264,254 | 14.63 |
In cerca di azioni più vendute allo scoperto?